DENTALCORP HOLDINGS LTD (DNTL.CA) Fundamental Analysis & Valuation

TSX:DNTL • CA24874B1085

11 CAD
+0.01 (+0.09%)
Last: Jan 16, 2026, 07:00 PM

This DNTL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

DNTL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Providers & Services industry. DNTL has a medium profitability rating, but doesn't score so well on its financial health evaluation. DNTL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. DNTL.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DNTL was profitable.
  • In the past year DNTL had a positive cash flow from operations.
  • In the past 5 years DNTL always reported negative net income.
  • DNTL had a positive operating cash flow in 4 of the past 5 years.
DNTL.CA Yearly Net Income VS EBIT VS OCF VS FCFDNTL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • DNTL has a Return On Assets (-0.79%) which is in line with its industry peers.
  • With a Return On Equity value of -1.54%, DNTL perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • With a Return On Invested Capital value of 1.65%, DNTL perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DNTL is significantly below the industry average of 7.68%.
  • The 3 year average ROIC (0.59%) for DNTL is below the current ROIC(1.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.79%
ROE -1.54%
ROIC 1.65%
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
DNTL.CA Yearly ROA, ROE, ROICDNTL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20 -25

1.3 Margins

  • Looking at the Operating Margin, with a value of 4.46%, DNTL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DNTL has grown nicely.
  • Looking at the Gross Margin, with a value of 50.16%, DNTL is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
  • DNTL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.46%
PM (TTM) N/A
GM 50.16%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
DNTL.CA Yearly Profit, Operating, Gross MarginsDNTL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. DNTL.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DNTL is destroying value.
  • Compared to 1 year ago, DNTL has more shares outstanding
  • Compared to 5 years ago, DNTL has more shares outstanding
  • Compared to 1 year ago, DNTL has an improved debt to assets ratio.
DNTL.CA Yearly Shares OutstandingDNTL.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNTL.CA Yearly Total Debt VS Total AssetsDNTL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • DNTL has an Altman-Z score of 0.98. This is a bad value and indicates that DNTL is not financially healthy and even has some risk of bankruptcy.
  • DNTL has a Altman-Z score (0.98) which is in line with its industry peers.
  • The Debt to FCF ratio of DNTL is 8.17, which is on the high side as it means it would take DNTL, 8.17 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 8.17, DNTL perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • DNTL has a Debt/Equity ratio of 0.77. This is a neutral value indicating DNTL is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.77, DNTL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.17
Altman-Z 0.98
ROIC/WACC0.2
WACC8.06%
DNTL.CA Yearly LT Debt VS Equity VS FCFDNTL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • DNTL has a Current Ratio of 0.86. This is a bad value and indicates that DNTL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 0.86, DNTL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • A Quick Ratio of 0.72 indicates that DNTL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.72, DNTL is in line with its industry, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.72
DNTL.CA Yearly Current Assets VS Current LiabilitesDNTL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. DNTL.CA Growth Analysis

3.1 Past

  • DNTL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.41%, which is quite impressive.
  • Looking at the last year, DNTL shows a quite strong growth in Revenue. The Revenue has grown by 10.09% in the last year.
  • Measured over the past years, DNTL shows a quite strong growth in Revenue. The Revenue has been growing by 15.02% on average per year.
EPS 1Y (TTM)97.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%366.67%
Revenue 1Y (TTM)10.09%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%11.91%

3.2 Future

  • Based on estimates for the next years, DNTL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.29% on average per year.
  • DNTL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.46% yearly.
EPS Next Y31.85%
EPS Next 2Y23.19%
EPS Next 3Y14.29%
EPS Next 5YN/A
Revenue Next Year10.54%
Revenue Next 2Y10.67%
Revenue Next 3Y9.73%
Revenue Next 5Y7.46%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DNTL.CA Yearly Revenue VS EstimatesDNTL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNTL.CA Yearly EPS VS EstimatesDNTL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

5

4. DNTL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.75, DNTL is valued on the expensive side.
  • Based on the Price/Earnings ratio, DNTL is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • DNTL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.45.
  • With a Price/Forward Earnings ratio of 17.68, DNTL is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, DNTL is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • DNTL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.65.
Industry RankSector Rank
PE 20.75
Fwd PE 17.68
DNTL.CA Price Earnings VS Forward Price EarningsDNTL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 73.33% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.32
EV/EBITDA 12.95
DNTL.CA Per share dataDNTL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • DNTL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DNTL's earnings are expected to grow with 14.29% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y23.19%
EPS Next 3Y14.29%

1

5. DNTL.CA Dividend Analysis

5.1 Amount

  • DNTL has a yearly dividend return of 0.91%, which is pretty low.
  • DNTL's Dividend Yield is a higher than the industry average which is at 1.37.
  • With a Dividend Yield of 0.91, DNTL pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

  • DNTL does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DNTL.CA Yearly Dividends per shareDNTL.CA Yearly Dividends per shareYearly Dividends per share 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DPN/A
EPS Next 2Y23.19%
EPS Next 3Y14.29%
DNTL.CA Yearly Income VS Free CF VS DividendDNTL.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

DNTL.CA Fundamentals: All Metrics, Ratios and Statistics

DENTALCORP HOLDINGS LTD

TSX:DNTL (1/16/2026, 7:00:00 PM)

11

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners21.49%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap2.10B
Revenue(TTM)1.66B
Net Income(TTM)-27.30M
Analysts72.31
Price Target11.33 (3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.65%
Min EPS beat(2)-9.48%
Max EPS beat(2)24.78%
EPS beat(4)2
Avg EPS beat(4)-0.07%
Min EPS beat(4)-32.39%
Max EPS beat(4)24.78%
EPS beat(8)4
Avg EPS beat(8)-18.25%
EPS beat(12)7
Avg EPS beat(12)9.89%
EPS beat(16)8
Avg EPS beat(16)-4.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-1.56%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)-0.81%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)2
Avg Revenue beat(12)-1.37%
Revenue beat(16)3
Avg Revenue beat(16)-1.16%
PT rev (1m)-1.03%
PT rev (3m)-7.41%
EPS NQ rev (1m)7.41%
EPS NQ rev (3m)6.62%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)18.57%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 20.75
Fwd PE 17.68
P/S 1.27
P/FCF 12.32
P/OCF 8.96
P/B 1.19
P/tB N/A
EV/EBITDA 12.95
EPS(TTM)0.53
EY4.82%
EPS(NY)0.62
Fwd EY5.66%
FCF(TTM)0.89
FCFY8.11%
OCF(TTM)1.23
OCFY11.16%
SpS8.69
BVpS9.26
TBVpS-4.54
PEG (NY)0.65
PEG (5Y)N/A
Graham Number10.51
Profitability
Industry RankSector Rank
ROA -0.79%
ROE -1.54%
ROCE 2.29%
ROIC 1.65%
ROICexc 1.68%
ROICexgc 9.86%
OM 4.46%
PM (TTM) N/A
GM 50.16%
FCFM 10.28%
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
ROICexc(3y)0.6%
ROICexc(5y)N/A
ROICexgc(3y)3.44%
ROICexgc(5y)N/A
ROCE(3y)0.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y24.24%
ROICexc growth 3YN/A
ROICexc growth 5Y27.79%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.17
Debt/EBITDA 5.14
Cap/Depr 33.53%
Cap/Sales 3.86%
Interest Coverage 0.86
Cash Conversion 88.51%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.72
Altman-Z 0.98
F-Score6
WACC8.06%
ROIC/WACC0.2
Cap/Depr(3y)18.24%
Cap/Depr(5y)15.74%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%366.67%
EPS Next Y31.85%
EPS Next 2Y23.19%
EPS Next 3Y14.29%
EPS Next 5YN/A
Revenue 1Y (TTM)10.09%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%11.91%
Revenue Next Year10.54%
Revenue Next 2Y10.67%
Revenue Next 3Y9.73%
Revenue Next 5Y7.46%
EBIT growth 1Y72.16%
EBIT growth 3YN/A
EBIT growth 5Y36.31%
EBIT Next Year85.67%
EBIT Next 3Y30.91%
EBIT Next 5Y18.52%
FCF growth 1Y89.57%
FCF growth 3Y58.7%
FCF growth 5Y157.47%
OCF growth 1Y92.7%
OCF growth 3Y52.18%
OCF growth 5Y50.41%

DENTALCORP HOLDINGS LTD / DNTL.CA FAQ

Can you provide the ChartMill fundamental rating for DENTALCORP HOLDINGS LTD?

ChartMill assigns a fundamental rating of 4 / 10 to DNTL.CA.


What is the valuation status for DNTL stock?

ChartMill assigns a valuation rating of 5 / 10 to DENTALCORP HOLDINGS LTD (DNTL.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for DENTALCORP HOLDINGS LTD?

DENTALCORP HOLDINGS LTD (DNTL.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for DNTL stock?

The financial health rating of DENTALCORP HOLDINGS LTD (DNTL.CA) is 3 / 10.